ANNAMYCIN III - Acute Myeloid Leukemia
Clinical Trial Grant
Awarded By
Moleculin Biotech, Inc.
Start Date
April 25, 2022
End Date
May 31, 2025
Awarded By
Moleculin Biotech, Inc.
Start Date
April 25, 2022
End Date
May 31, 2025